GSK : GSK

All GSK Articles

256 Articles

Douglas A. McIntyre | Aug 20, 2007 at 4:42 AM EDT

Europe Markets 8/20/2007

Markets in Europe were higher at 5,40 AM New York time. The FTSE rose 1% to 6,126. BHP Billiton (BHP)…

Douglas A. McIntyre | Aug 6, 2007 at 4:53 AM EDT

Europe Markets 8/6/2007

Markets in Europe were off modestly at 5.50 AM New York time. The FTSE fell .2% to 6,211. Barclays (BCS)…

Douglas A. McIntyre | Aug 2, 2007 at 8:42 AM EDT

Pozen (POZN): Another Microcap Biotech Falls Apart

Pozen (POZN) got the bad news that the FDA has "delayed approval of an experimental two-in-one migraine drug from GlaxoSmithKline…

Douglas A. McIntyre | Aug 2, 2007 at 6:49 AM EDT

Amgen (AMGN) And GSK (GSK): Is The Government Getting Tougher On Pharma?

The U.S. Centers for Medicare & Medicaid Services issued its final ruling governing use of a class of anemia drugs…

Douglas A. McIntyre | Aug 2, 2007 at 6:00 AM EDT

Europe Markets 8/2/2007

Markets in Europe were higher at 6.50 AM New York time. The FTSE rose .7% to 6,295. BP (BP) was…

Douglas A. McIntyre | Jul 31, 2007 at 5:04 AM EDT

Europe Markets 7/31/2007 Big Rally

Markets in Europe were up sharply at 6 AM New York time. The FTSE rose 1.6% to 6,306. Barclays (BCS)…

Douglas A. McIntyre | Jul 30, 2007 at 9:45 AM EDT

GSK (GSK): Repeat After Me: Avandia Is OK

GlaxoSmithKline (GSK) wants everyone, including the FDA, to know that its diabetes drug Avadia is "safe and effective when used…

Douglas A. McIntyre | Jul 27, 2007 at 6:06 AM EDT

Amgen’s (AMGN) Troubled Quarter

Amgen (AMGN) actually rallied a bit after hours yesterday. But, revenue growth was hard to come by. Amgen reported net…

Douglas A. McIntyre | Jul 25, 2007 at 6:29 AM EDT

Glaxo (GSK) Misses, But Starts Big Share Buy-Back

Sales of GlaxoSmithKline’s (GSK) Avandia products for diabetes dropped 22% because of health concerns about the drug. And the company’s…

Douglas A. McIntyre | Jul 14, 2007 at 9:31 AM EDT

Results-Based Pharma (JNJ)(GSK)

Imagine that if an aspirin did not get rid of you headache. And, the company that made the pain killer…

Douglas A. McIntyre | Jun 24, 2007 at 12:16 PM EDT

Mixed Short Interest in Drug & Medical Stocks (June 2007)

As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a…

Douglas A. McIntyre | Jun 13, 2007 at 1:04 PM EDT

New Threat for GlaxoSmithKline: Avandia Spammers (GSK)

GlaxoSmithKline (GSK-NYSE) has been under significant pressure of late because of the New England Journal of Medicine showing greatly increased…

Douglas A. McIntyre | Jun 12, 2007 at 5:53 PM EDT

Cramer’s Picks & Pans in Pharmaceuticals

Stock Tickers: MRK, PFE, JNJ, GSK, SGP, LLY, WYE, NVS, NVO On tonight’s MAD MONEY on CNBC, Jim Cramer said…

Douglas A. McIntyre | Jun 6, 2007 at 7:13 AM EDT

Pre-Market Stock News (June 6, 2007)

(AAUK) Anglo American’s CEO will become a non-executive member of the board of directors at BP (BP).(ACAD) Acadia Pharmaceuticals traded…

Douglas A. McIntyre | May 30, 2007 at 6:30 PM EDT

Biotechs & Pharmas Bracing For ASCO Annual Meeting

This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology. …

1 … 15 16 17 18

GSK : GSK

All GSK Articles

Europe Markets 8/20/2007

Europe Markets 8/6/2007

Pozen (POZN): Another Microcap Biotech Falls Apart

Amgen (AMGN) And GSK (GSK): Is The Government Getting Tougher On Pharma?

Europe Markets 8/2/2007

Europe Markets 7/31/2007 Big Rally

GSK (GSK): Repeat After Me: Avandia Is OK

Amgen’s (AMGN) Troubled Quarter

Glaxo (GSK) Misses, But Starts Big Share Buy-Back

Results-Based Pharma (JNJ)(GSK)

Mixed Short Interest in Drug & Medical Stocks (June 2007)

New Threat for GlaxoSmithKline: Avandia Spammers (GSK)

Cramer’s Picks & Pans in Pharmaceuticals

Pre-Market Stock News (June 6, 2007)

Biotechs & Pharmas Bracing For ASCO Annual Meeting

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Semiconductor ETF SOXX Delivers 50% YTD—Reddit Retail Cautious Despite Record-Breaking Run

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

GSK : GSK

All GSK Articles

Europe Markets 8/20/2007

Europe Markets 8/6/2007

Pozen (POZN): Another Microcap Biotech Falls Apart

Amgen (AMGN) And GSK (GSK): Is The Government Getting Tougher On Pharma?

Europe Markets 8/2/2007

Europe Markets 7/31/2007 Big Rally

GSK (GSK): Repeat After Me: Avandia Is OK

Amgen’s (AMGN) Troubled Quarter

Glaxo (GSK) Misses, But Starts Big Share Buy-Back

Results-Based Pharma (JNJ)(GSK)

Mixed Short Interest in Drug & Medical Stocks (June 2007)

New Threat for GlaxoSmithKline: Avandia Spammers (GSK)

Cramer’s Picks & Pans in Pharmaceuticals

Pre-Market Stock News (June 6, 2007)

Biotechs & Pharmas Bracing For ASCO Annual Meeting

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Semiconductor ETF SOXX Delivers 50% YTD—Reddit Retail Cautious Despite Record-Breaking Run

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s